Gluten Peptide Test · Stool

If you have celiac disease, the only treatment is removing gluten from your diet completely. The problem is that gluten hides in places most people would never suspect, including sauces, processed foods, shared kitchen surfaces, restaurant fryers, and even some medications. This test looks for actual fragments of gluten protein in your stool, giving you direct proof of whether any gluten has been reaching your gut over the past several days.

What makes stool gluten peptide testing different from a blood test is that it measures recent exposure rather than your immune system's longer-term response. You can have normal celiac antibodies, feel completely fine, follow what you believe is a strict gluten-free diet, and still test positive. Studies of treated celiac patients show this happens in roughly one in four to one in two people who consider themselves fully compliant.

What This Test Actually Measures

Gluten is a complex protein found in wheat, rye, and barley. Most proteins get fully broken down by your digestive enzymes, but gluten contains stretches that are unusually rich in two amino acids (proline and glutamine) that human enzymes cannot fully cut apart. The result is a set of stable, digestion-resistant fragments called gluten immunogenic peptides, or GIP. The most studied of these is a 33-amino-acid fragment of alpha-gliadin (the part of wheat gluten that drives most of the immune trouble in celiac disease).

Because these fragments survive digestion, a measurable amount passes through your gut and ends up in stool. The test uses antibodies (called G12 and A1) that latch onto these specific peptides, giving a clear yes-or-no answer about whether gluten was eaten, plus a number reflecting how much. Stool measurements reflect gluten intake over roughly four to seven days, with peak detection 12 to 36 hours after eating and signal still measurable up to five days after a one-gram exposure.

Why It Matters in Celiac Disease

Celiac disease is an autoimmune condition where gluten triggers your immune system to attack the lining of your small intestine. Untreated, this damages the finger-like projections (called villi) that absorb nutrients, leading to anemia, bone loss, fatigue, and a long list of other complications. Even small amounts of ongoing gluten exposure can keep this damage going, even when you feel fine.

Repeated stool gluten peptide testing tracks closely with whether your gut is actually healing. In treated celiac patients, persistent positive results predict ongoing villous damage on biopsy, while consistent negative results predict mucosal healing with high accuracy. Repeated absence of urinary GIP over three days reached 94% sensitivity and 97% negative predictive value for mucosal damage in one study. Stool tests perform similarly or better.

Hidden Exposures Most People Miss

Across multiple prospective studies, 20% to 50% of treated celiac patients who self-report strict adherence and have negative blood tests still show detectable gluten peptides in stool. Many of these patients have no symptoms at all. The exposures that get missed are usually small, scattered, and unintentional, including cross-contamination from shared cookware, oats processed in wheat facilities, hidden gluten in restaurant sauces and broths, and trace amounts in medications and supplements.

The pattern is most pronounced in adolescents and adult men, who in some series show transgression rates as high as 60%. This is behavioral rather than a quirk of the test. The test simply makes the exposure visible.

Relationship to Mucosal Healing

Detectable gluten peptides correlate strongly with the type of intestinal damage seen on biopsy (Marsh grade II to III). In a systematic review, GIP detection had a 33% to 100% association with histologic abnormalities, compared to 25% to 39% for celiac antibody tests and even less for symptom questionnaires. Repeated negative GIP results, on the other hand, are one of the strongest predictors that your gut lining is recovering.

This matters because mucosal healing is the actual goal of treatment. People who heal their gut lining have lower long-term risks of complications. Antibody tests can lag behind real exposure and can miss small, intermittent transgressions entirely. A direct measurement of what is actually entering your gut closes that gap.

Sorting Out Refractory Versus Non-Responsive Celiac Disease

Some people on a gluten-free diet continue to have symptoms or persistent intestinal damage. The traditional concern is that they have refractory celiac disease, a serious condition that sometimes requires immunosuppressant medications. Stool gluten peptide testing has changed this picture. In one study of patients labeled refractory, repeated GIP testing identified ongoing gluten exposure as the actual cause in most cases, allowing them to avoid immunosuppression and instead get more intensive dietary support.

Reference Values

The thresholds below come from validated stool ELISA studies in adult celiac populations using the G12 antibody assay. Different labs may use slightly different detection limits and report cutoffs in different units. Compare your results within the same lab over time for the most meaningful trend.

What this means for you: A single negative test is reassuring but not definitive, because gluten exposure is intermittent. A single positive is meaningful, but the most useful pattern comes from a series of tests over time.

Why One Reading Is Not Enough

Gluten exposure is, by its nature, sporadic. You might be perfect for two weeks and then unknowingly eat contaminated food at a restaurant. A single stool sample taken on a clean week could easily come back negative even if you have meaningful exposure on other weeks. Modeling of low-dose gluten challenges shows that a single sample picks up only about 71% of 50 milligram exposures, while three samples over three to four days lifts sensitivity above 90%. In healthy adults under controlled conditions, the within-person variability in fecal GIP measures around 20% (a moderate degree of variation that means small fluctuations are normal).

A practical and well-validated approach is testing twice within a 7-day window, repeated periodically. Get a baseline. If positive, retest after refining your diet to confirm whether the change worked. If negative, retest in a different week to verify the pattern. Once stable, check at least every 6 to 12 months, or any time symptoms return or eating habits change.

What to Do If Your Result Is Positive

A positive result means gluten reached your gut recently. It does not necessarily mean you cheated. The most useful next step is detective work, not guilt. Review the past 5 days of food carefully, including restaurant meals, sauces, soy sauce, oats, supplements, medications, and shared kitchen tools. Consider working with a dietitian who specializes in celiac disease, because the most common sources of hidden gluten are not obvious without expert eyes.

Companion tests that help interpret a positive result include tissue transglutaminase IgA (tTG-IgA) and deamidated gliadin peptide IgG (DGP-IgG) antibodies, which together show whether your immune system is also reacting, and serum IgA to make sure antibody tests are valid. If positives persist despite a careful diet review, a follow-up duodenal biopsy with a gastroenterologist familiar with celiac disease can confirm whether mucosal damage is ongoing. Repeatedly negative GIP testing alongside normalizing antibodies is a strong signal that your gut is healing.

When Results Can Be Misleading

• Recent diet change: if you have only been on a strict gluten-free diet for a few days before testing, peptides from earlier exposure may still be detectable. Wait at least a week of strict eating before drawing conclusions about adherence.
• Sample timing: gluten peptides peak in stool 12 to 36 hours after a meal and decline over the next several days. A single negative could reflect a quiet stretch rather than full clearance.
• Very low exposures: at the assay's lowest detection limit, between-test variability is high. A single barely-positive result is best confirmed with a repeat sample.
• Children versus adults: studies in children sometimes find that GIP results do not correlate with reported adherence, suggesting that pediatric exposure patterns and reporting accuracy may differ. Interpret pediatric results with input from a clinician familiar with celiac disease in kids.